A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the substance there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Express Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source.
Some experts said the demand for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, risking fines, legal action or imprisonment.
Service Response and Material Elimination
Based on TikTok, the service has taken down violative material and banned associated keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or injecting at home.
Within moments of entering one community, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these communities, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially significant health risks”.
